207 related articles for article (PubMed ID: 30209774)
1. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.
Kallianpur AR; Gittleman H; Letendre S; Ellis R; Barnholtz-Sloan JS; Bush WS; Heaton R; Samuels DC; Franklin DR; Rosario-Cookson D; Clifford DB; Collier AC; Gelman B; Marra CM; McArthur JC; McCutchan JA; Morgello S; Grant I; Simpson D; Connor JR; Hulgan T;
Mol Neurobiol; 2019 May; 56(5):3808-3818. PubMed ID: 30209774
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.
Mehta SR; Pérez-Santiago J; Hulgan T; Day TR; Barnholtz-Sloan J; Gittleman H; Letendre S; Ellis R; Heaton R; Patton S; Suben JD; Franklin D; Rosario D; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur J; McCutchan A; Morgello S; Simpson D; Connor J; Grant I; Kallianpur A
J Neuroinflammation; 2017 Mar; 14(1):72. PubMed ID: 28359324
[TBL] [Abstract][Full Text] [Related]
3. Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.
Campbell LM; Fennema-Notestine C; Saloner R; Hussain M; Chen A; Franklin D; Umlauf A; Ellis RJ; Collier AC; Marra CM; Clifford DB; Gelman BB; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Heaton RK;
J Int Neuropsychol Soc; 2020 Feb; 26(2):147-162. PubMed ID: 31576785
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.
Patton SM; Wang Q; Hulgan T; Connor JR; Jia P; Zhao Z; Letendre SL; Ellis RJ; Bush WS; Samuels DC; Franklin DR; Kaur H; Iudicello J; Grant I; Kallianpur AR
Fluids Barriers CNS; 2017 Apr; 14(1):11. PubMed ID: 28427421
[TBL] [Abstract][Full Text] [Related]
6. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR;
Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399
[TBL] [Abstract][Full Text] [Related]
8. Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIV.
Kaur H; Bush WS; Letendre SL; Ellis RJ; Heaton RK; Patton SM; Connor JR; Samuels DC; Franklin DR; Hulgan T; Kallianpur AR
Mol Neurobiol; 2021 Oct; 58(10):4842-4855. PubMed ID: 34195939
[TBL] [Abstract][Full Text] [Related]
9. Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment.
Ellis RJ; Chenna A; Petropoulos CJ; Lie Y; Curanovic D; Crescini M; Winslow J; Sundermann E; Tang B; Letendre SL
J Neurovirol; 2022 Jun; 28(3):438-445. PubMed ID: 35674935
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.
Hulgan T; Kallianpur AR; Guo Y; Barnholtz-Sloan JS; Gittleman H; Brown TT; Ellis R; Letendre S; Heaton RK; Samuels DC;
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e95-e102. PubMed ID: 30531306
[TBL] [Abstract][Full Text] [Related]
11. Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders.
Barco A; Orlando S; Stroffolini G; Pirriatore V; Lazzaro A; Vai D; Guastamacchia G; Noce G; Atzori C; Trunfio M; Bonora S; Di Perri G; Calcagno A
J Neurovirol; 2022 Apr; 28(2):226-235. PubMed ID: 35044644
[TBL] [Abstract][Full Text] [Related]
12. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
13. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.
Burdo TH; Weiffenbach A; Woods SP; Letendre S; Ellis RJ; Williams KC
AIDS; 2013 Jun; 27(9):1387-95. PubMed ID: 23435298
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.
Suh HS; Lo Y; Choi N; Letendre S; Lee SC
J Neuroinflammation; 2015 Apr; 12():72. PubMed ID: 25890304
[TBL] [Abstract][Full Text] [Related]
16. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
[TBL] [Abstract][Full Text] [Related]
17. Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.
Yuan L; Qiao L; Wei F; Yin J; Liu L; Ji Y; Smith D; Li N; Chen D
J Neurovirol; 2013 Apr; 19(2):144-9. PubMed ID: 23389619
[TBL] [Abstract][Full Text] [Related]
18. Human pegivirus-1 in the CSF of patients with HIV-associated neurocognitive disorder (HAND) may be derived from blood in highly viraemic patients.
Hardie D; Smuts H
J Clin Virol; 2017 Jun; 91():58-61. PubMed ID: 28499138
[TBL] [Abstract][Full Text] [Related]
19. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
Letendre S; Bharti A; Perez-Valero I; Hanson B; Franklin D; Woods SP; Gianella S; de Oliveira MF; Heaton RK; Grant I; Landay AL; Lurain N;
Clin Infect Dis; 2018 Aug; 67(5):770-777. PubMed ID: 29506084
[TBL] [Abstract][Full Text] [Related]
20. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]